Status:
COMPLETED
Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder
Lead Sponsor:
Pharmacology Research Institute
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The purpose is to evaluate the safety and usefulness of the investigational drug, vilazodone in depression.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Male or female patients 18-65 years of age, inclusive.
Exclusion
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00290914
Last Update
May 9 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.